Target intelligence / Profile preview

Leucine-rich repeat transmembrane protein 3 (LRTM3)

Target
LRTM3
Molecular classification
Other (Leucine-rich repeat transmembrane protein; not classified as GPCR, ion channel, enzyme, transporter, or transcription factor)
01

Overview

Leucine-rich repeat transmembrane protein 3 (LRTM3) is a human protein consisting of a series of leucine-rich repeats and a transmembrane domain, encoded by the LRTM3 gene. Although its detailed biological function is poorly understood, proteins with leucine-rich repeats often participate in protein–protein interactions and signaling processes in cells. It is not classified as a major receptor, enzyme, transporter, or other molecular target for drugs, and there is no current evidence for its involvement in human disease, clinical pharmacology, or role as a therapeutic or diagnostic biomarker. Multiple synonymous gene names and aliases exist in databases, but these all refer to the same gene product. There are no known drugs or ligands that specifically interact with LRTM3. If more structured disease, function, or interaction data emerges, definitions should be updated. For now, LRTM3 is best categorized as an orphan or non-target transmembrane protein with poorly defined biological and medical significance.

Other names
Leucine-rich repeat transmembrane protein 3LRTM3Coiled-coil domain-containing protein 168CCDC168C13orf40FLJ40176Leucine-rich repeat transmembrane protein CCDC168Coiled-coil domain containing 168
02

Mechanism of action

None identified — Mechanisms for drugs or ligands targeting this molecule are not described in current literature.

03

Biological functions

Other (very limited data available; leucine-rich repeat proteins often function in protein–protein interactions, cell signaling, and structural scaffolding, but the specific role of LRTM3 is not defined in publicly available literature)
04

Disease associations

Other (No direct or well-established disease associations are documented for LRTM3. However, family members in leucine-rich repeat protein families can be implicated in neurological or developmental processes)

Beyond the preview

Go deeper on Leucine-rich repeat transmembrane protein 3 (LRTM3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leucine-rich repeat transmembrane protein 3 (LRTM3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call